CANNAPHARMARX, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CANNAPHARMARX, INC. (CPMD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 629.42 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-31
- CANNAPHARMARX, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2015-03-31 was 4.28M shares.
- CANNAPHARMARX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 629.42K shares, a 0.00% change from fiscal 2024.
- CANNAPHARMARX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 629.42K shares.
- CANNAPHARMARX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 750.00K shares.
- CANNAPHARMARX, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2014 was 3.90M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | 629.42K shares 10-K · filed 2026-03-31 | |||
| 2024-12-31 | 629.42K shares 10-K · filed 2026-03-31 | |||
| 2019-12-31 | 750.00K shares 10-K · filed 2020-05-27 | |||
| 2015-09-30 | 4.67M shares 10-Q · filed 2015-11-13 | |||
| 2015-06-30 | 4.42M shares 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | 4.28M shares 10-Q · filed 2015-05-14 | |||
| 2014-12-31 | 3.90M shares 10-K · filed 2015-03-31 |